✦ LIBER ✦

A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma

✍ Scribed by L. C. Scott; J. C. Yao; A. B. Benson; A. L. Thomas; S. Falk; R. R. Mena; J. Picus; J. Wright; M. F. Mulcahy; J. A. Ajani; T. R. J. Evans

Publisher: Springer
Year: 2008
Tongue: English
Weight: 276 KB
Volume: 63
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0746-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of induction irinotecan-c

Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma

✍ Fernando Rivera; Maica Galán; Josep Tabernero; Andres Cervantes; Mª Eugenia Vega 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 351 KB

A phase II open-label study of DHA-pacli

A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma

✍ Robert J. Jones; Robert E. Hawkins; Martin M. Eatock; David R. Ferry; Ferry A. L 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 265 KB

A phase-II study of combination of pegyl

A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer

✍ Kaisa Leea Sunela; Sanna Koskinen; Pirkko-Liisa Kellokumpu-Lehtinen 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 348 KB

A phase I/II study of oxaliplatin and pa

A phase I/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische Onkologie

✍ Volker Kaechele; Markus Moehler; Manfred P. Lutz; Goetz von Wichert; Miriam Eise 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 214 KB

Phase II clinical trial of SKI-2053R, a

Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma

✍ Noe K. Kim; Seock-Ah Im; Dong-Wan Kim; Moon H. Lee; Chul W. Jung; Eun K. Cho; Jo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

BACKGROUND. SKI-2053R (SK Chemicals, Kyungki-Do, South Korea) is a new platinum derivative with antitumor activity against various cell lines, including cisplatin-resistant tumor cell lines. Preclinical studies have suggested that it is less nephrotoxic than cisplatin. This study evaluated the effic

Phase II study of 5-fluorouracil and fol

Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A southwest oncology group study

✍ Jeffrey L. Berenberg; Catherine Tangen; John S. Macdonald; Laura F. Hutchins; Ro 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 3 views